Methylation of LOXL1 Promoter by DNMT3A in Aged Human Skin Fibroblasts

L Moulin, V Cenizo, AN Antu, V André, S Pain… - Rejuvenation …, 2017 - liebertpub.com
L Moulin, V Cenizo, AN Antu, V André, S Pain, P Sommer, R Debret
Rejuvenation Research, 2017liebertpub.com
Abstract Lysyl oxidase-like 1 (LOXL1) is an amino-oxidase involved in maturation of elastic
fibers. Its downregulation has been associated with elastic fibers repair loss in aging aorta,
lung, ligament, and skin. Several evidences of LOXL1 epigenetic silencing by promoter
methylation were reported in cancer and cutis laxa syndrome. We hypothesized that this
mechanism could be implicated in skin aging process, as far as elastic fibers are also
concerned. Anti-DNMT3A chromatin immunoprecipitation was conducted with nuclear …
Abstract
Lysyl oxidase-like 1 (LOXL1) is an amino-oxidase involved in maturation of elastic fibers. Its downregulation has been associated with elastic fibers repair loss in aging aorta, lung, ligament, and skin. Several evidences of LOXL1 epigenetic silencing by promoter methylation were reported in cancer and cutis laxa syndrome. We hypothesized that this mechanism could be implicated in skin aging process, as far as elastic fibers are also concerned. Anti-DNMT3A chromatin immunoprecipitation was conducted with nuclear extracts from skin fibroblasts isolated from young and elderly individuals, and showed a higher level of DNMT3A protein binding to the LOXL1 promoter in older cells concomitantly to the decrease of LOXL1 mRNA expression and the increase of LOXL1 promoter methylation. Using luciferase reporter assay driven by LOXL1 promoter in HEK293 cells, we demonstrated that LOXL1 transcriptional activity was dramatically reduced when a recombinant DNMT3A was concomitantly overexpressed. LOXL1 promoter transcriptional activity was restored in the presence of a broad-spectrum inhibitor of DNMT activity, 5-aza-2′-deoxycytidine. Finally, to assess whether the interplay between DNMT3A and LOXL1 promoter could be targeted to increase LOXL1 mRNA expression level, an Origanum majorana extract was selected among 43 plant extracts as a new inhibitor of human DNMT3A activity to restore LOXL1 secretion without cytotoxicity in aged skin fibroblasts.
Mary Ann Liebert